Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia

Published:2020-08-21 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Zhang Yi,Qian Jie-Jing,Zhou Yi-Le,Huang Xin,Li Jian-Hu,Li Xue-Ying,Li Chen-Ying,Wang Huan-Ping,Lou Yin-Jun,Meng Hai-Tao,Yu Wen-Juan,Tong Hong-Yan,Jin Jie,Zhu Hong-Hu

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference24 articles.

1. How I treat T-cell acute lymphoblastic leukemia in adults;Litzow;Blood.,2015

2. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993);Marks;Blood.,2009

3. Classification systems for acute and chronic leukaemias;Szczepanski;Best Pract Res Clin Haematol.,2003

4. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia;Coustan-Smith;Lancet Oncol.,2009

5. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype;Jain;Blood.,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed;Med;2024-08

2. MN1::ETV6‐positive de novo T‐cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report;British Journal of Haematology;2024-04-29

3. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China;Annals of Hematology;2024-04-06

4. Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review;International Journal of Hematology;2023-06-03

5. End of induction MRD assessment based early treatment intensification with novel agents in ETP-ALL- may be the way forward;Blood Research;2023-05-10